CA2398861A1 - Gene disruption methodologies for drug target discovery - Google Patents

Info

Publication number

CA2398861A1

CA2398861A1 CA002398861A CA2398861A CA2398861A1 CA 2398861 A1 CA2398861 A1 CA 2398861A1 CA 002398861 A CA002398861 A CA 002398861A CA 2398861 A CA2398861 A CA 2398861A CA 2398861 A1 CA2398861 A1 CA 2398861A1

Authority

CA

Canada

Prior art keywords

gene

cells

seq

nucleotide sequence

genes

Prior art date

2000-02-18

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 108090000623 proteins and genes Proteins 0.000 title claims abstract description 933
• 238000000034 method Methods 0.000 title claims abstract description 330
• 239000003596 drug target Substances 0.000 title description 58
• 102000004169 proteins and genes Human genes 0.000 claims abstract description 172
• 230000014509 gene expression Effects 0.000 claims abstract description 144
• 108700028369 Alleles Proteins 0.000 claims abstract description 143
• 230000001018 virulence Effects 0.000 claims abstract description 128
• 239000002773 nucleotide Substances 0.000 claims abstract description 114
• 125000003729 nucleotide group Chemical group 0.000 claims abstract description 113
• 230000007918 pathogenicity Effects 0.000 claims abstract description 97
• 108700039887 Essential Genes Proteins 0.000 claims abstract description 87
• 238000012216 screening Methods 0.000 claims abstract description 30
• 241000222120 Candida <Saccharomycetales> Species 0.000 claims abstract description 20
• 239000000203 mixture Substances 0.000 claims abstract description 18
• 238000009396 hybridization Methods 0.000 claims abstract description 17
• 208000015181 infectious disease Diseases 0.000 claims abstract description 11
• 210000004027 cell Anatomy 0.000 claims description 263
• 150000001875 compounds Chemical class 0.000 claims description 238
• 241000222122 Candida albicans Species 0.000 claims description 137
• 230000012010 growth Effects 0.000 claims description 119
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 114
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 107
• 230000002538 fungal effect Effects 0.000 claims description 100
• 102000039446 nucleic acids Human genes 0.000 claims description 94
• 108020004707 nucleic acids Proteins 0.000 claims description 94
• 150000007523 nucleic acids Chemical class 0.000 claims description 94
• 229920001184 polypeptide Polymers 0.000 claims description 92
• 238000012360 testing method Methods 0.000 claims description 90
• 230000000694 effects Effects 0.000 claims description 70
• 230000027455 binding Effects 0.000 claims description 60
• 229940095731 candida albicans Drugs 0.000 claims description 60
• 238000009739 binding Methods 0.000 claims description 59
• 241000894007 species Species 0.000 claims description 58
• 239000012634 fragment Substances 0.000 claims description 52
• 230000035755 proliferation Effects 0.000 claims description 52
• 239000003814 drug Substances 0.000 claims description 47
• 241001465754 Metazoa Species 0.000 claims description 46
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 46
• 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 45
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 45
• 244000053095 fungal pathogen Species 0.000 claims description 44
• 230000004083 survival effect Effects 0.000 claims description 44
• 230000000692 anti-sense effect Effects 0.000 claims description 43
• 108020004414 DNA Proteins 0.000 claims description 39
• 230000001105 regulatory effect Effects 0.000 claims description 39
• 108020001507 fusion proteins Proteins 0.000 claims description 34
• 241000282414 Homo sapiens Species 0.000 claims description 31
• 102000037865 fusion proteins Human genes 0.000 claims description 30
• 239000003550 marker Substances 0.000 claims description 30
• 241001225321 Aspergillus fumigatus Species 0.000 claims description 27
• 238000013518 transcription Methods 0.000 claims description 27
• 230000035897 transcription Effects 0.000 claims description 27
• 108090000994 Catalytic RNA Proteins 0.000 claims description 23
• 102000053642 Catalytic RNA Human genes 0.000 claims description 23
• 108091092562 ribozyme Proteins 0.000 claims description 23
• 241000221204 Cryptococcus neoformans Species 0.000 claims description 22
• 239000013598 vector Substances 0.000 claims description 22
• 241000233866 Fungi Species 0.000 claims description 21
• 201000007336 Cryptococcosis Diseases 0.000 claims description 19
• 230000000295 complement effect Effects 0.000 claims description 19
• 201000010099 disease Diseases 0.000 claims description 19
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 19
• 241000228212 Aspergillus Species 0.000 claims description 18
• 241000228245 Aspergillus niger Species 0.000 claims description 18
• 108091026890 Coding region Proteins 0.000 claims description 17
• 241000221300 Puccinia Species 0.000 claims description 17
• 241001533598 Septoria Species 0.000 claims description 17
• 241000223231 Trichosporon beigelii Species 0.000 claims description 17
• 244000301083 Ustilago maydis Species 0.000 claims description 17
• 230000015572 biosynthetic process Effects 0.000 claims description 17
• 230000006798 recombination Effects 0.000 claims description 17
• 230000002829 reductive effect Effects 0.000 claims description 17
• 241001149952 Amylomyces rouxii Species 0.000 claims description 16
• 241000223205 Coccidioides immitis Species 0.000 claims description 16
• 241000228404 Histoplasma capsulatum Species 0.000 claims description 16
• 241000235525 Rhizomucor pusillus Species 0.000 claims description 16
• 240000005384 Rhizopus oryzae Species 0.000 claims description 16
• 235000013752 Rhizopus oryzae Nutrition 0.000 claims description 16
• 235000015919 Ustilago maydis Nutrition 0.000 claims description 16
• 229940091771 aspergillus fumigatus Drugs 0.000 claims description 16
• 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 claims description 16
• 238000005215 recombination Methods 0.000 claims description 16
• 230000035899 viability Effects 0.000 claims description 16
• 241000235389 Absidia Species 0.000 claims description 15
• 241001480061 Blumeria graminis Species 0.000 claims description 15
• 241000123650 Botrytis cinerea Species 0.000 claims description 15
• 241001344131 Magnaporthe grisea Species 0.000 claims description 15
• 230000002401 inhibitory effect Effects 0.000 claims description 15
• 241000222173 Candida parapsilosis Species 0.000 claims description 14
• 241000222178 Candida tropicalis Species 0.000 claims description 14
• 241000223221 Fusarium oxysporum Species 0.000 claims description 14
• 241000722096 Tilletia controversa Species 0.000 claims description 14
• 230000004568 DNA-binding Effects 0.000 claims description 13
• 241000235645 Pichia kudriavzevii Species 0.000 claims description 13
• 230000002147 killing effect Effects 0.000 claims description 13
• 238000012258 culturing Methods 0.000 claims description 11
• 238000004519 manufacturing process Methods 0.000 claims description 11
• 241000233872 Pneumocystis carinii Species 0.000 claims description 10
• 238000011282 treatment Methods 0.000 claims description 10
• 229940121375 antifungal agent Drugs 0.000 claims description 9
• 239000003429 antifungal agent Substances 0.000 claims description 9
• 229940124597 therapeutic agent Drugs 0.000 claims description 9
• 230000028993 immune response Effects 0.000 claims description 8
• 230000003068 static effect Effects 0.000 claims description 8
• 230000004071 biological effect Effects 0.000 claims description 7
• 241000222126 [Candida] glabrata Species 0.000 claims description 6
• 208000032343 candida glabrata infection Diseases 0.000 claims description 6
• 239000003795 chemical substances by application Substances 0.000 claims description 6
• 210000001840 diploid cell Anatomy 0.000 claims description 6
• 239000003937 drug carrier Substances 0.000 claims description 6
• 230000001665 lethal effect Effects 0.000 claims description 6
• 230000009467 reduction Effects 0.000 claims description 6
• 230000002103 transcriptional effect Effects 0.000 claims description 6
• 241000736122 Parastagonospora nodorum Species 0.000 claims description 5
• 241000221301 Puccinia graminis Species 0.000 claims description 5
• 230000004913 activation Effects 0.000 claims description 5
• 230000001857 anti-mycotic effect Effects 0.000 claims description 5
• 239000002543 antimycotic Substances 0.000 claims description 5
• 210000004748 cultured cell Anatomy 0.000 claims description 5
• 230000002255 enzymatic effect Effects 0.000 claims description 5
• 231100000518 lethal Toxicity 0.000 claims description 5
• 239000008194 pharmaceutical composition Substances 0.000 claims description 5
• 230000019491 signal transduction Effects 0.000 claims description 5
• 241000787361 Parastagonospora avenae Species 0.000 claims description 4
• 241001123583 Puccinia striiformis Species 0.000 claims description 4
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
• 241000722093 Tilletia caries Species 0.000 claims description 4
• 230000030570 cellular localization Effects 0.000 claims description 4
• 238000002493 microarray Methods 0.000 claims description 4
• 238000002360 preparation method Methods 0.000 claims description 4
• 230000017066 negative regulation of growth Effects 0.000 claims description 3
• 230000004543 DNA replication Effects 0.000 claims description 2
• 241000124008 Mammalia Species 0.000 claims description 2
• 230000001851 biosynthetic effect Effects 0.000 claims description 2
• 230000015556 catabolic process Effects 0.000 claims description 2
• 239000011780 sodium chloride Substances 0.000 claims description 2
• 239000001509 sodium citrate Substances 0.000 claims description 2
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 2
• 241000271566 Aves Species 0.000 claims 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 claims 1
• 150000001722 carbon compounds Chemical class 0.000 claims 1
• 230000032823 cell division Effects 0.000 claims 1
• 238000011109 contamination Methods 0.000 claims 1
• 102000040811 transporter activity Human genes 0.000 claims 1
• 108091092194 transporter activity Proteins 0.000 claims 1
• 244000052769 pathogen Species 0.000 abstract description 70
• 238000003556 assay Methods 0.000 abstract description 45
• 238000007877 drug screening Methods 0.000 abstract description 19
• 238000010276 construction Methods 0.000 abstract description 16
• 230000002068 genetic effect Effects 0.000 abstract description 15
• 238000011161 development Methods 0.000 abstract description 14
• 238000007876 drug discovery Methods 0.000 abstract description 9
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract description 6
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract description 6
• 239000002547 new drug Substances 0.000 abstract description 5
• 238000003491 array Methods 0.000 abstract description 2
• 239000000047 product Substances 0.000 description 216
• 235000018102 proteins Nutrition 0.000 description 104
• 229930101283 tetracycline Natural products 0.000 description 62
• 239000004098 Tetracycline Substances 0.000 description 61
• 229960002180 tetracycline Drugs 0.000 description 61
• 235000019364 tetracycline Nutrition 0.000 description 61
• 150000003522 tetracyclines Chemical class 0.000 description 61
• 108091028043 Nucleic acid sequence Proteins 0.000 description 50
• 229920002477 rna polymer Polymers 0.000 description 42
• 230000001717 pathogenic effect Effects 0.000 description 36
• 229940079593 drug Drugs 0.000 description 35
• 230000000670 limiting effect Effects 0.000 description 33
• 230000003115 biocidal effect Effects 0.000 description 31
• 108091034117 Oligonucleotide Proteins 0.000 description 30
• 108020004999 messenger RNA Proteins 0.000 description 28
• 230000037361 pathway Effects 0.000 description 26
• 230000008569 process Effects 0.000 description 26
• 230000001413 cellular effect Effects 0.000 description 25
• 230000003993 interaction Effects 0.000 description 25
• 241000196324 Embryophyta Species 0.000 description 24
• 102000040430 polynucleotide Human genes 0.000 description 24
• 108091033319 polynucleotide Proteins 0.000 description 24
• 239000002157 polynucleotide Substances 0.000 description 24
• 239000000411 inducer Substances 0.000 description 23
• 238000013459 approach Methods 0.000 description 22
• 239000000306 component Substances 0.000 description 22
• 230000035772 mutation Effects 0.000 description 22
• 239000000126 substance Substances 0.000 description 21
• 238000000423 cell based assay Methods 0.000 description 20
• 238000010200 validation analysis Methods 0.000 description 20
• 235000001014 amino acid Nutrition 0.000 description 18
• 238000006243 chemical reaction Methods 0.000 description 18
• 230000006870 function Effects 0.000 description 18
• 102000004190 Enzymes Human genes 0.000 description 17
• 108090000790 Enzymes Proteins 0.000 description 17
• 229940088598 enzyme Drugs 0.000 description 17
• 108091023040 Transcription factor Proteins 0.000 description 16
• 229940024606 amino acid Drugs 0.000 description 16
• 150000001413 amino acids Chemical class 0.000 description 16
• 230000001225 therapeutic effect Effects 0.000 description 16
• 238000000338 in vitro Methods 0.000 description 15
• 239000002609 medium Substances 0.000 description 15
• 239000013612 plasmid Substances 0.000 description 15
• 230000014616 translation Effects 0.000 description 15
• 239000003242 anti bacterial agent Substances 0.000 description 14
• 238000013519 translation Methods 0.000 description 14
• 230000000875 corresponding effect Effects 0.000 description 13
• 238000001514 detection method Methods 0.000 description 13
• 230000018109 developmental process Effects 0.000 description 13
• 239000013604 expression vector Substances 0.000 description 13
• 239000003112 inhibitor Substances 0.000 description 13
• 238000003752 polymerase chain reaction Methods 0.000 description 13
• 230000003389 potentiating effect Effects 0.000 description 13
• 239000007787 solid Substances 0.000 description 13
• 230000009036 growth inhibition Effects 0.000 description 12
• 238000001727 in vivo Methods 0.000 description 12
• 238000003786 synthesis reaction Methods 0.000 description 12
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 11
• 125000000539 amino acid group Chemical group 0.000 description 11
• 229940088710 antibiotic agent Drugs 0.000 description 11
• 238000003776 cleavage reaction Methods 0.000 description 11
• 239000002299 complementary DNA Substances 0.000 description 11
• 239000013615 primer Substances 0.000 description 11
• 230000007017 scission Effects 0.000 description 11
• 230000035945 sensitivity Effects 0.000 description 11
• 102000040945 Transcription factor Human genes 0.000 description 10
• 238000007792 addition Methods 0.000 description 10
• 238000000099 in vitro assay Methods 0.000 description 10
• 230000002779 inactivation Effects 0.000 description 10
• 239000000463 material Substances 0.000 description 10
• 230000004048 modification Effects 0.000 description 10
• 238000012986 modification Methods 0.000 description 10
• 101150061166 tetR gene Proteins 0.000 description 10
• 241000588724 Escherichia coli Species 0.000 description 9
• 108700026244 Open Reading Frames Proteins 0.000 description 9
• 230000008236 biological pathway Effects 0.000 description 9
• 239000003153 chemical reaction reagent Substances 0.000 description 9
• 238000005516 engineering process Methods 0.000 description 9
• 230000002452 interceptive effect Effects 0.000 description 9
• 239000011541 reaction mixture Substances 0.000 description 9
• 230000000754 repressing effect Effects 0.000 description 9
• 239000000243 solution Substances 0.000 description 9
• 238000011144 upstream manufacturing Methods 0.000 description 9
• 108700010070 Codon Usage Proteins 0.000 description 8
• 206010028980 Neoplasm Diseases 0.000 description 8
• 108020004511 Recombinant DNA Proteins 0.000 description 8
• 108091081024 Start codon Proteins 0.000 description 8
• 238000012217 deletion Methods 0.000 description 8
• 230000037430 deletion Effects 0.000 description 8
• 238000003780 insertion Methods 0.000 description 8
• 230000037431 insertion Effects 0.000 description 8
• 239000007790 solid phase Substances 0.000 description 8
• 238000010561 standard procedure Methods 0.000 description 8
• 239000000758 substrate Substances 0.000 description 8
• 229920000936 Agarose Polymers 0.000 description 7
• 241000235070 Saccharomyces Species 0.000 description 7
• 230000009471 action Effects 0.000 description 7
• 239000011324 bead Substances 0.000 description 7
• 230000000855 fungicidal effect Effects 0.000 description 7
• 238000002744 homologous recombination Methods 0.000 description 7
• 230000006801 homologous recombination Effects 0.000 description 7
• 239000007791 liquid phase Substances 0.000 description 7
• 238000000746 purification Methods 0.000 description 7
• 108020003175 receptors Proteins 0.000 description 7
• 102000005962 receptors Human genes 0.000 description 7
• SEHFUALWMUWDKS-UHFFFAOYSA-N 5-fluoroorotic acid Chemical compound OC(=O)C=1NC(=O)NC(=O)C=1F SEHFUALWMUWDKS-UHFFFAOYSA-N 0.000 description 6
• KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical compound NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 6
• 108020004705 Codon Proteins 0.000 description 6
• 241000282412 Homo Species 0.000 description 6
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 6
• 241000700605 Viruses Species 0.000 description 6
• 238000004458 analytical method Methods 0.000 description 6
• 239000000427 antigen Substances 0.000 description 6
• 108091007433 antigens Proteins 0.000 description 6
• 102000036639 antigens Human genes 0.000 description 6
• 201000011510 cancer Diseases 0.000 description 6
• 210000000349 chromosome Anatomy 0.000 description 6
• 239000003184 complementary RNA Substances 0.000 description 6
• 235000005911 diet Nutrition 0.000 description 6
• 230000037213 diet Effects 0.000 description 6
• 231100000673 dose–response relationship Toxicity 0.000 description 6
• 238000002474 experimental method Methods 0.000 description 6
• 239000000284 extract Substances 0.000 description 6
• 230000013595 glycosylation Effects 0.000 description 6
• 238000006206 glycosylation reaction Methods 0.000 description 6
• 210000004408 hybridoma Anatomy 0.000 description 6
• 230000001965 increasing effect Effects 0.000 description 6
• 230000005764 inhibitory process Effects 0.000 description 6
• 238000010369 molecular cloning Methods 0.000 description 6
• 230000008506 pathogenesis Effects 0.000 description 6
• 238000012545 processing Methods 0.000 description 6
• 239000000523 sample Substances 0.000 description 6
• 230000009466 transformation Effects 0.000 description 6
• 108020005544 Antisense RNA Proteins 0.000 description 5
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
• 108010070675 Glutathione transferase Proteins 0.000 description 5
• 102000005720 Glutathione transferase Human genes 0.000 description 5
• 108060003951 Immunoglobulin Proteins 0.000 description 5
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
• 238000012300 Sequence Analysis Methods 0.000 description 5
• 101150050575 URA3 gene Proteins 0.000 description 5
• 239000002253 acid Substances 0.000 description 5
• 230000004927 fusion Effects 0.000 description 5
• 239000008103 glucose Substances 0.000 description 5
• 102000018358 immunoglobulin Human genes 0.000 description 5
• 230000001939 inductive effect Effects 0.000 description 5
• 238000005259 measurement Methods 0.000 description 5
• 239000012071 phase Substances 0.000 description 5
• 230000010076 replication Effects 0.000 description 5
• 238000007423 screening assay Methods 0.000 description 5
• 238000012163 sequencing technique Methods 0.000 description 5
• 238000005406 washing Methods 0.000 description 5
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
• 229920001503 Glucan Polymers 0.000 description 4
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 4
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 4
• 101100246753 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) pyrF gene Proteins 0.000 description 4
• 108010003774 Histidinol-phosphatase Proteins 0.000 description 4
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 4
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
• 108010076504 Protein Sorting Signals Proteins 0.000 description 4
• 238000002105 Southern blotting Methods 0.000 description 4
• 239000002671 adjuvant Substances 0.000 description 4
• 238000010171 animal model Methods 0.000 description 4
• 230000001580 bacterial effect Effects 0.000 description 4
• 230000030833 cell death Effects 0.000 description 4
• 230000010261 cell growth Effects 0.000 description 4
• 210000002421 cell wall Anatomy 0.000 description 4
• 230000009918 complex formation Effects 0.000 description 4
• 239000003623 enhancer Substances 0.000 description 4
• 238000011156 evaluation Methods 0.000 description 4
• 230000004992 fission Effects 0.000 description 4
• RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 4
• 229960004884 fluconazole Drugs 0.000 description 4
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
• 239000005090 green fluorescent protein Substances 0.000 description 4
• 239000001963 growth medium Substances 0.000 description 4
• 201000009085 invasive aspergillosis Diseases 0.000 description 4
• 239000003446 ligand Substances 0.000 description 4
• 229920002521 macromolecule Polymers 0.000 description 4
• 230000007246 mechanism Effects 0.000 description 4
• 230000001404 mediated effect Effects 0.000 description 4
• 230000003287 optical effect Effects 0.000 description 4
• 210000001519 tissue Anatomy 0.000 description 4
• 241000701161 unidentified adenovirus Species 0.000 description 4
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
• 101100036901 Arabidopsis thaliana RPL40B gene Proteins 0.000 description 3
• 241000351920 Aspergillus nidulans Species 0.000 description 3
• 241000221198 Basidiomycota Species 0.000 description 3
• 229930105110 Cyclosporin A Natural products 0.000 description 3
• 108010036949 Cyclosporine Proteins 0.000 description 3
• 102100039556 Galectin-4 Human genes 0.000 description 3
• 108700007698 Genetic Terminator Regions Proteins 0.000 description 3
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
• 101150009006 HIS3 gene Proteins 0.000 description 3
• 101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 3
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 3
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 3
• 239000004472 Lysine Substances 0.000 description 3
• 241000699660 Mus musculus Species 0.000 description 3
• 108091005804 Peptidases Proteins 0.000 description 3
• 241000235648 Pichia Species 0.000 description 3
• 101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 3
• 102000002278 Ribosomal Proteins Human genes 0.000 description 3
• 108010000605 Ribosomal Proteins Proteins 0.000 description 3
• 101100123443 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HAP4 gene Proteins 0.000 description 3
• 241000251131 Sphyrna Species 0.000 description 3
• 229930189330 Streptothricin Natural products 0.000 description 3
• 241000209140 Triticum Species 0.000 description 3
• 235000021307 Triticum Nutrition 0.000 description 3
• 230000021736 acetylation Effects 0.000 description 3
• 238000006640 acetylation reaction Methods 0.000 description 3
• 150000007513 acids Chemical class 0.000 description 3
• 239000012190 activator Substances 0.000 description 3
• 230000000843 anti-fungal effect Effects 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 230000033228 biological regulation Effects 0.000 description 3
• 238000012512 characterization method Methods 0.000 description 3
• 238000004587 chromatography analysis Methods 0.000 description 3
• 229960001265 ciclosporin Drugs 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 238000009509 drug development Methods 0.000 description 3
• 239000012636 effector Substances 0.000 description 3
• 230000001747 exhibiting effect Effects 0.000 description 3
• 238000013537 high throughput screening Methods 0.000 description 3
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
• 230000001976 improved effect Effects 0.000 description 3
• 238000011534 incubation Methods 0.000 description 3
• 238000002372 labelling Methods 0.000 description 3
• 238000002844 melting Methods 0.000 description 3
• 230000008018 melting Effects 0.000 description 3
• 230000000813 microbial effect Effects 0.000 description 3
• 231100000252 nontoxic Toxicity 0.000 description 3
• 230000003000 nontoxic effect Effects 0.000 description 3
• 230000026731 phosphorylation Effects 0.000 description 3
• 238000006366 phosphorylation reaction Methods 0.000 description 3
• 230000004481 post-translational protein modification Effects 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• 238000012552 review Methods 0.000 description 3
• 238000011218 seed culture Methods 0.000 description 3
• 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 3
• 150000003384 small molecules Chemical class 0.000 description 3
• NRAUADCLPJTGSF-VLSXYIQESA-N streptothricin F Chemical compound NCCC[C@H](N)CC(=O)N[C@@H]1[C@H](O)[C@@H](OC(N)=O)[C@@H](CO)O[C@H]1\N=C/1N[C@H](C(=O)NC[C@H]2O)[C@@H]2N\1 NRAUADCLPJTGSF-VLSXYIQESA-N 0.000 description 3
• 238000006467 substitution reaction Methods 0.000 description 3
• 230000009897 systematic effect Effects 0.000 description 3
• QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 3
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 3
• 238000011830 transgenic mouse model Methods 0.000 description 3
• 230000032258 transport Effects 0.000 description 3
• 230000001960 triggered effect Effects 0.000 description 3
• 229940035893 uracil Drugs 0.000 description 3
• 239000003981 vehicle Substances 0.000 description 3
• 239000000304 virulence factor Substances 0.000 description 3
• RFLVMTUMFYRZCB-UHFFFAOYSA-N 1-methylguanine Chemical compound O=C1N(C)C(N)=NC2=C1N=CN2 RFLVMTUMFYRZCB-UHFFFAOYSA-N 0.000 description 2
• YSAJFXWTVFGPAX-UHFFFAOYSA-N 2-[(2,4-dioxo-1h-pyrimidin-5-yl)oxy]acetic acid Chemical compound OC(=O)COC1=CNC(=O)NC1=O YSAJFXWTVFGPAX-UHFFFAOYSA-N 0.000 description 2
• FZWGECJQACGGTI-UHFFFAOYSA-N 2-amino-7-methyl-1,7-dihydro-6H-purin-6-one Chemical compound NC1=NC(O)=C2N(C)C=NC2=N1 FZWGECJQACGGTI-UHFFFAOYSA-N 0.000 description 2
• OIVLITBTBDPEFK-UHFFFAOYSA-N 5,6-dihydrouracil Chemical compound O=C1CCNC(=O)N1 OIVLITBTBDPEFK-UHFFFAOYSA-N 0.000 description 2
• UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 2
• ZLAQATDNGLKIEV-UHFFFAOYSA-N 5-methyl-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound CC1=CNC(=S)NC1=O ZLAQATDNGLKIEV-UHFFFAOYSA-N 0.000 description 2
• LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
• 229920001817 Agar Polymers 0.000 description 2
• 241000223600 Alternaria Species 0.000 description 2
• 241000235349 Ascomycota Species 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 241000335423 Blastomyces Species 0.000 description 2
• 108091007914 CDKs Proteins 0.000 description 2
• 101150092493 CREA gene Proteins 0.000 description 2
• 101100454117 Candida albicans KRE9 gene Proteins 0.000 description 2
• 241001527609 Cryptococcus Species 0.000 description 2
• 108090000266 Cyclin-dependent kinases Proteins 0.000 description 2
• 102000003903 Cyclin-dependent kinases Human genes 0.000 description 2
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 2
• 102000053602 DNA Human genes 0.000 description 2
• 206010059866 Drug resistance Diseases 0.000 description 2
• 238000002965 ELISA Methods 0.000 description 2
• 108700024394 Exon Proteins 0.000 description 2
• 108700005088 Fungal Genes Proteins 0.000 description 2
• 206010017533 Fungal infection Diseases 0.000 description 2
• 241000223218 Fusarium Species 0.000 description 2
• 102000013446 GTP Phosphohydrolases Human genes 0.000 description 2
• 108091006109 GTPases Proteins 0.000 description 2
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
• 108010024636 Glutathione Proteins 0.000 description 2
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
• 241000699666 Mus <mouse, genus> Species 0.000 description 2
• 101100018717 Mus musculus Il1rl1 gene Proteins 0.000 description 2
• 241000699670 Mus sp. Species 0.000 description 2
• 208000031888 Mycoses Diseases 0.000 description 2
• HYVABZIGRDEKCD-UHFFFAOYSA-N N(6)-dimethylallyladenine Chemical compound CC(C)=CCNC1=NC=NC2=C1N=CN2 HYVABZIGRDEKCD-UHFFFAOYSA-N 0.000 description 2
• 208000031662 Noncommunicable disease Diseases 0.000 description 2
• 101710163270 Nuclease Proteins 0.000 description 2
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
• 102000016304 Origin Recognition Complex Human genes 0.000 description 2
• 108010067244 Origin Recognition Complex Proteins 0.000 description 2
• 238000012408 PCR amplification Methods 0.000 description 2
• 229930012538 Paclitaxel Natural products 0.000 description 2
• 102000035195 Peptidases Human genes 0.000 description 2
• 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 2
• 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 2
• 241000233622 Phytophthora infestans Species 0.000 description 2
• 101100505672 Podospora anserina grisea gene Proteins 0.000 description 2
• 241001123569 Puccinia recondita Species 0.000 description 2
• 241000223252 Rhodotorula Species 0.000 description 2
• 101150006985 STE2 gene Proteins 0.000 description 2
• 101100204213 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) STE3 gene Proteins 0.000 description 2
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
• QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 2
• 102000010823 Telomere-Binding Proteins Human genes 0.000 description 2
• 108010038599 Telomere-Binding Proteins Proteins 0.000 description 2
• 241000722133 Tilletia Species 0.000 description 2
• 241000723873 Tobacco mosaic virus Species 0.000 description 2
• 108020004566 Transfer RNA Proteins 0.000 description 2
• 108090000631 Trypsin Proteins 0.000 description 2
• 102000004142 Trypsin Human genes 0.000 description 2
• 108090000704 Tubulin Proteins 0.000 description 2
• 102000004243 Tubulin Human genes 0.000 description 2
• 241000700618 Vaccinia virus Species 0.000 description 2
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
• 238000001042 affinity chromatography Methods 0.000 description 2
• 239000008272 agar Substances 0.000 description 2
• 238000004873 anchoring Methods 0.000 description 2
• 244000037640 animal pathogen Species 0.000 description 2
• 230000001093 anti-cancer Effects 0.000 description 2
• 210000003719 b-lymphocyte Anatomy 0.000 description 2
• 230000008827 biological function Effects 0.000 description 2
• 229960002685 biotin Drugs 0.000 description 2
• 235000020958 biotin Nutrition 0.000 description 2
• 239000011616 biotin Substances 0.000 description 2
• 239000000872 buffer Substances 0.000 description 2
• 230000003197 catalytic effect Effects 0.000 description 2
• 150000001768 cations Chemical class 0.000 description 2
• 210000000170 cell membrane Anatomy 0.000 description 2
• 230000004663 cell proliferation Effects 0.000 description 2
• 230000003833 cell viability Effects 0.000 description 2
• 230000004715 cellular signal transduction Effects 0.000 description 2
• 239000007795 chemical reaction product Substances 0.000 description 2
• 239000013611 chromosomal DNA Substances 0.000 description 2
• 230000002759 chromosomal effect Effects 0.000 description 2
• 238000010367 cloning Methods 0.000 description 2
• 239000011248 coating agent Substances 0.000 description 2
• 238000000576 coating method Methods 0.000 description 2
• 230000001276 controlling effect Effects 0.000 description 2
• 230000003436 cytoskeletal effect Effects 0.000 description 2
• 230000001086 cytosolic effect Effects 0.000 description 2
• 230000001472 cytotoxic effect Effects 0.000 description 2
• 230000007547 defect Effects 0.000 description 2
• 230000006735 deficit Effects 0.000 description 2
• 238000013461 design Methods 0.000 description 2
• 231100000676 disease causative agent Toxicity 0.000 description 2
• 238000001035 drying Methods 0.000 description 2
• 238000001962 electrophoresis Methods 0.000 description 2
• 230000002616 endonucleolytic effect Effects 0.000 description 2
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
• 238000012268 genome sequencing Methods 0.000 description 2
• 229960003180 glutathione Drugs 0.000 description 2
• 230000009643 growth defect Effects 0.000 description 2
• 210000003783 haploid cell Anatomy 0.000 description 2
• 229920000140 heteropolymer Polymers 0.000 description 2
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
• 230000007062 hydrolysis Effects 0.000 description 2
• 238000006460 hydrolysis reaction Methods 0.000 description 2
• FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
• 238000002347 injection Methods 0.000 description 2
• 239000007924 injection Substances 0.000 description 2
• 230000010354 integration Effects 0.000 description 2
• 230000003834 intracellular effect Effects 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• 231100000225 lethality Toxicity 0.000 description 2
• 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
• 239000002502 liposome Substances 0.000 description 2
• 210000002540 macrophage Anatomy 0.000 description 2
• 210000004962 mammalian cell Anatomy 0.000 description 2
• 230000010534 mechanism of action Effects 0.000 description 2
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
• -1 methocycline Chemical compound 0.000 description 2
• YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 2
• 244000000010 microbial pathogen Species 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 230000000869 mutational effect Effects 0.000 description 2
• 239000002853 nucleic acid probe Substances 0.000 description 2
• 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 2
• 229960001592 paclitaxel Drugs 0.000 description 2
• 244000045947 parasite Species 0.000 description 2
• 238000002823 phage display Methods 0.000 description 2
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
• 230000010399 physical interaction Effects 0.000 description 2
• 230000035479 physiological effects, processes and functions Effects 0.000 description 2
• 244000000003 plant pathogen Species 0.000 description 2
• 238000001556 precipitation Methods 0.000 description 2
• 238000000159 protein binding assay Methods 0.000 description 2
• 230000002285 radioactive effect Effects 0.000 description 2
• 239000012857 radioactive material Substances 0.000 description 2
• 238000009790 rate-determining step (RDS) Methods 0.000 description 2
• 239000000376 reactant Substances 0.000 description 2
• 238000003259 recombinant expression Methods 0.000 description 2
• 238000010839 reverse transcription Methods 0.000 description 2
• 101150026210 sat1 gene Proteins 0.000 description 2
• 230000003248 secreting effect Effects 0.000 description 2
• 230000001568 sexual effect Effects 0.000 description 2
• 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
• 239000011343 solid material Substances 0.000 description 2
• 235000000346 sugar Nutrition 0.000 description 2
• 208000024891 symptom Diseases 0.000 description 2
• 230000008685 targeting Effects 0.000 description 2
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 2
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
• 108091006106 transcriptional activators Proteins 0.000 description 2
• 238000011269 treatment regimen Methods 0.000 description 2
• 239000012588 trypsin Substances 0.000 description 2
• 238000003160 two-hybrid assay Methods 0.000 description 2
• 230000003612 virological effect Effects 0.000 description 2
• 230000007923 virulence factor Effects 0.000 description 2
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• CADQNXRGRFJSQY-UOWFLXDJSA-N (2r,3r,4r)-2-fluoro-2,3,4,5-tetrahydroxypentanal Chemical compound OC[C@@H](O)[C@@H](O)[C@@](O)(F)C=O CADQNXRGRFJSQY-UOWFLXDJSA-N 0.000 description 1
• ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
• RNIADBXQDMCFEN-IWVLMIASSA-N (4s,4ar,5s,5ar,12ar)-7-chloro-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C=C1C2=C(Cl)C=CC(O)=C2C(O)=C2[C@@H]1[C@H](O)[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O RNIADBXQDMCFEN-IWVLMIASSA-N 0.000 description 1
• SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
• GUXHBMASAHGULD-SEYHBJAFSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1([C@H]2O)=C(Cl)C=CC(O)=C1C(O)=C1[C@@H]2C[C@H]2[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]2(O)C1=O GUXHBMASAHGULD-SEYHBJAFSA-N 0.000 description 1
• PEQMJVGRHNZPAM-UHFFFAOYSA-N 1,4-dichloro-2-isocyanatobenzene Chemical compound ClC1=CC=C(Cl)C(N=C=O)=C1 PEQMJVGRHNZPAM-UHFFFAOYSA-N 0.000 description 1
• WJNGQIYEQLPJMN-IOSLPCCCSA-N 1-methylinosine Chemical compound C1=NC=2C(=O)N(C)C=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O WJNGQIYEQLPJMN-IOSLPCCCSA-N 0.000 description 1
• GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
• UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
• HLYBTPMYFWWNJN-UHFFFAOYSA-N 2-(2,4-dioxo-1h-pyrimidin-5-yl)-2-hydroxyacetic acid Chemical compound OC(=O)C(O)C1=CNC(=O)NC1=O HLYBTPMYFWWNJN-UHFFFAOYSA-N 0.000 description 1
• SGAKLDIYNFXTCK-UHFFFAOYSA-N 2-[(2,4-dioxo-1h-pyrimidin-5-yl)methylamino]acetic acid Chemical compound OC(=O)CNCC1=CNC(=O)NC1=O SGAKLDIYNFXTCK-UHFFFAOYSA-N 0.000 description 1
• QRBLKGHRWFGINE-UGWAGOLRSA-N 2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2r,3s,4s,5s,6s)-3-[(2s,3r,4r,5s)-4-carbamoyl-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)- Chemical compound N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(C)=O)NC(=O)C(C)C(O)C(C)NC(=O)C(C(O[C@H]1[C@@]([C@@H](O)[C@H](O)[C@H](CO)O1)(C)O[C@H]1[C@@H]([C@](O)([C@@H](O)C(CO)O1)C(N)=O)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C QRBLKGHRWFGINE-UGWAGOLRSA-N 0.000 description 1
• BFFPVEVGHKMWLT-UHFFFAOYSA-N 2-amino-3,7-dihydropurin-6-one;3,7-dihydropurin-6-one Chemical compound O=C1NC=NC2=C1NC=N2.O=C1NC(N)=NC2=C1NC=N2 BFFPVEVGHKMWLT-UHFFFAOYSA-N 0.000 description 1
• XMSMHKMPBNTBOD-UHFFFAOYSA-N 2-dimethylamino-6-hydroxypurine Chemical compound N1C(N(C)C)=NC(=O)C2=C1N=CN2 XMSMHKMPBNTBOD-UHFFFAOYSA-N 0.000 description 1
• SMADWRYCYBUIKH-UHFFFAOYSA-N 2-methyl-7h-purin-6-amine Chemical compound CC1=NC(N)=C2NC=NC2=N1 SMADWRYCYBUIKH-UHFFFAOYSA-N 0.000 description 1
• 101150055869 25 gene Proteins 0.000 description 1
• KOLPWZCZXAMXKS-UHFFFAOYSA-N 3-methylcytosine Chemical compound CN1C(N)=CC=NC1=O KOLPWZCZXAMXKS-UHFFFAOYSA-N 0.000 description 1
• OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
• WTJXVDPDEQKTCV-UHFFFAOYSA-N 4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide;hydron;chloride Chemical compound Cl.C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2C1CC1C(N(C)C)C(=O)C(C(N)=O)=C(O)C1(O)C2=O WTJXVDPDEQKTCV-UHFFFAOYSA-N 0.000 description 1
• GJAKJCICANKRFD-UHFFFAOYSA-N 4-acetyl-4-amino-1,3-dihydropyrimidin-2-one Chemical compound CC(=O)C1(N)NC(=O)NC=C1 GJAKJCICANKRFD-UHFFFAOYSA-N 0.000 description 1
• OVONXEQGWXGFJD-UHFFFAOYSA-N 4-sulfanylidene-1h-pyrimidin-2-one Chemical compound SC=1C=CNC(=O)N=1 OVONXEQGWXGFJD-UHFFFAOYSA-N 0.000 description 1
• YVMBAUWDIGJRNY-BESUKNQGSA-N 4o8o7q7iu4 Chemical compound C1C(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@@H](C)[C@@H](C(C)C)OC(=O)C2=CCCN2C(=O)C2=COC1=N2.N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2CCC(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O YVMBAUWDIGJRNY-BESUKNQGSA-N 0.000 description 1
• MQJSSLBGAQJNER-UHFFFAOYSA-N 5-(methylaminomethyl)-1h-pyrimidine-2,4-dione Chemical compound CNCC1=CNC(=O)NC1=O MQJSSLBGAQJNER-UHFFFAOYSA-N 0.000 description 1
• WPYRHVXCOQLYLY-UHFFFAOYSA-N 5-[(methoxyamino)methyl]-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound CONCC1=CNC(=S)NC1=O WPYRHVXCOQLYLY-UHFFFAOYSA-N 0.000 description 1
• LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical compound BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 1
• VKLFQTYNHLDMDP-PNHWDRBUSA-N 5-carboxymethylaminomethyl-2-thiouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=S)NC(=O)C(CNCC(O)=O)=C1 VKLFQTYNHLDMDP-PNHWDRBUSA-N 0.000 description 1
• ZFTBZKVVGZNMJR-UHFFFAOYSA-N 5-chlorouracil Chemical compound ClC1=CNC(=O)NC1=O ZFTBZKVVGZNMJR-UHFFFAOYSA-N 0.000 description 1
• KSNXJLQDQOIRIP-UHFFFAOYSA-N 5-iodouracil Chemical compound IC1=CNC(=O)NC1=O KSNXJLQDQOIRIP-UHFFFAOYSA-N 0.000 description 1
• KELXHQACBIUYSE-UHFFFAOYSA-N 5-methoxy-1h-pyrimidine-2,4-dione Chemical compound COC1=CNC(=O)NC1=O KELXHQACBIUYSE-UHFFFAOYSA-N 0.000 description 1
• 101150009299 5.1 gene Proteins 0.000 description 1
• DCPSTSVLRXOYGS-UHFFFAOYSA-N 6-amino-1h-pyrimidine-2-thione Chemical compound NC1=CC=NC(S)=N1 DCPSTSVLRXOYGS-UHFFFAOYSA-N 0.000 description 1
• CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
• 101150106774 9 gene Proteins 0.000 description 1
• MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
• 208000030507 AIDS Diseases 0.000 description 1
• 240000006409 Acacia auriculiformis Species 0.000 description 1
• 108010022752 Acetylcholinesterase Proteins 0.000 description 1
• 102000012440 Acetylcholinesterase Human genes 0.000 description 1
• 108010051457 Acid Phosphatase Proteins 0.000 description 1
• 102000013563 Acid Phosphatase Human genes 0.000 description 1
• 206010069754 Acquired gene mutation Diseases 0.000 description 1
• 102100029457 Adenine phosphoribosyltransferase Human genes 0.000 description 1
• 108010024223 Adenine phosphoribosyltransferase Proteins 0.000 description 1
• 108010000239 Aequorin Proteins 0.000 description 1
• 241000282996 Alces Species 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 108020004491 Antisense DNA Proteins 0.000 description 1
• 101100269449 Arabidopsis thaliana AHK4 gene Proteins 0.000 description 1
• 101100278439 Archaeoglobus fulgidus (strain ATCC 49558 / DSM 4304 / JCM 9628 / NBRC 100126 / VC-16) pol gene Proteins 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 241001480043 Arthrodermataceae Species 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 241000228197 Aspergillus flavus Species 0.000 description 1
• 235000007319 Avena orientalis Nutrition 0.000 description 1
• 244000075850 Avena orientalis Species 0.000 description 1
• 108090001008 Avidin Proteins 0.000 description 1
• 241000193755 Bacillus cereus Species 0.000 description 1
• 235000014469 Bacillus subtilis Nutrition 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• 102100030981 Beta-alanine-activating enzyme Human genes 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• 108091022894 CDPdiacylglycerol-Serine O-Phosphatidyltransferase Proteins 0.000 description 1
• 101100129088 Caenorhabditis elegans lys-2 gene Proteins 0.000 description 1
• 101710132601 Capsid protein Proteins 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 108010078791 Carrier Proteins Proteins 0.000 description 1
• 241000701489 Cauliflower mosaic virus Species 0.000 description 1
• 229920002101 Chitin Polymers 0.000 description 1
• 239000004099 Chlortetracycline Substances 0.000 description 1
• 241001508787 Citeromyces Species 0.000 description 1
• 241000221751 Claviceps purpurea Species 0.000 description 1
• 101710094648 Coat protein Proteins 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 108020004394 Complementary RNA Proteins 0.000 description 1
• 241000186216 Corynebacterium Species 0.000 description 1
• 241000221756 Cryphonectria parasitica Species 0.000 description 1
• 241000235646 Cyberlindnera jadinii Species 0.000 description 1
• 108050006400 Cyclin Proteins 0.000 description 1
• 102000016736 Cyclin Human genes 0.000 description 1
• IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
• ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
• 101150074155 DHFR gene Proteins 0.000 description 1
• 102000016559 DNA Primase Human genes 0.000 description 1
• 108010092681 DNA Primase Proteins 0.000 description 1
• 102000003844 DNA helicases Human genes 0.000 description 1
• 108090000133 DNA helicases Proteins 0.000 description 1
• 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
• 239000003155 DNA primer Substances 0.000 description 1
• 230000006820 DNA synthesis Effects 0.000 description 1
• 102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 1
• XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
• 241000235035 Debaryomyces Species 0.000 description 1
• CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
• 101710088194 Dehydrogenase Proteins 0.000 description 1
• FMTDIUIBLCQGJB-UHFFFAOYSA-N Demethylchlortetracyclin Natural products C1C2C(O)C3=C(Cl)C=CC(O)=C3C(=O)C2=C(O)C2(O)C1C(N(C)C)C(O)=C(C(N)=O)C2=O FMTDIUIBLCQGJB-UHFFFAOYSA-N 0.000 description 1
• 108700016256 Dihydropteroate synthases Proteins 0.000 description 1
• 235000019227 E-number Nutrition 0.000 description 1
• 239000004243 E-number Substances 0.000 description 1
• 108010093099 Endoribonucleases Proteins 0.000 description 1
• 102000002494 Endoribonucleases Human genes 0.000 description 1
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
• 241001465321 Eremothecium Species 0.000 description 1
• 241001465328 Eremothecium gossypii Species 0.000 description 1
• 241000221785 Erysiphales Species 0.000 description 1
• 241000221787 Erysiphe Species 0.000 description 1
• 101000798869 Escherichia phage Mu DDE-recombinase A Proteins 0.000 description 1
• 108050001049 Extracellular proteins Proteins 0.000 description 1
• 108010074860 Factor Xa Proteins 0.000 description 1
• BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
• GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
• 102100030393 G-patch domain and KOW motifs-containing protein Human genes 0.000 description 1
• 108091092584 GDNA Proteins 0.000 description 1
• 241001149504 Gaeumannomyces Species 0.000 description 1
• 206010064571 Gene mutation Diseases 0.000 description 1
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
• 241000159512 Geotrichum Species 0.000 description 1
• 241000250507 Gigaspora candida Species 0.000 description 1
• 241001492300 Gloeophyllum trabeum Species 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 244000068988 Glycine max Species 0.000 description 1
• 235000010469 Glycine max Nutrition 0.000 description 1
• 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
• 241001149669 Hanseniaspora Species 0.000 description 1
• 108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 description 1
• 241001640034 Heteropterys Species 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
• 241000228402 Histoplasma Species 0.000 description 1
• 101000773364 Homo sapiens Beta-alanine-activating enzyme Proteins 0.000 description 1
• 101000962438 Homo sapiens Protein MAL2 Proteins 0.000 description 1
• 240000005979 Hordeum vulgare Species 0.000 description 1
• 235000007340 Hordeum vulgare Nutrition 0.000 description 1
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
• 101100321817 Human parvovirus B19 (strain HV) 7.5K gene Proteins 0.000 description 1
• GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
• 101150062179 II gene Proteins 0.000 description 1
• 206010061598 Immunodeficiency Diseases 0.000 description 1
• 102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 1
• 108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 1
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 108020005350 Initiator Codon Proteins 0.000 description 1
• 229930010555 Inosine Natural products 0.000 description 1
• UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
• 101710088977 Inositol phosphorylceramide synthase catalytic subunit AUR1 Proteins 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• 108090000769 Isomerases Proteins 0.000 description 1
• 102000004195 Isomerases Human genes 0.000 description 1
• 101150067255 KRE6 gene Proteins 0.000 description 1
• 101150047618 KRE9 gene Proteins 0.000 description 1
• OYIFNHCXNCRBQI-BYPYZUCNSA-N L-2-aminoadipic acid Chemical compound OC(=O)[C@@H](N)CCCC(O)=O OYIFNHCXNCRBQI-BYPYZUCNSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• 101150022713 LAC4 gene Proteins 0.000 description 1
• 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
• 241000144128 Lichtheimia corymbifera Species 0.000 description 1
• 241001149698 Lipomyces Species 0.000 description 1
• 108060001084 Luciferase Proteins 0.000 description 1
• 239000005089 Luciferase Substances 0.000 description 1
• DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
• 102000006830 Luminescent Proteins Human genes 0.000 description 1
• 108010047357 Luminescent Proteins Proteins 0.000 description 1
• 241001344133 Magnaporthe Species 0.000 description 1
• 101710125418 Major capsid protein Proteins 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 102000029749 Microtubule Human genes 0.000 description 1
• 108091022875 Microtubule Proteins 0.000 description 1
• SGSSKEDGVONRGC-UHFFFAOYSA-N N(2)-methylguanine Chemical compound O=C1NC(NC)=NC2=C1N=CN2 SGSSKEDGVONRGC-UHFFFAOYSA-N 0.000 description 1
• BKAYIFDRRZZKNF-VIFPVBQESA-N N-acetylcarnosine Chemical compound CC(=O)NCCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 BKAYIFDRRZZKNF-VIFPVBQESA-N 0.000 description 1
• 241000221960 Neurospora Species 0.000 description 1
• 101100285000 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) his-3 gene Proteins 0.000 description 1
• 108091092724 Noncoding DNA Proteins 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 101710141454 Nucleoprotein Proteins 0.000 description 1
• 241000320412 Ogataea angusta Species 0.000 description 1
• 241000221671 Ophiostoma ulmi Species 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 240000007594 Oryza sativa Species 0.000 description 1
• 235000007164 Oryza sativa Nutrition 0.000 description 1
• 206010061535 Ovarian neoplasm Diseases 0.000 description 1
• 239000004100 Oxytetracycline Substances 0.000 description 1
• 238000010222 PCR analysis Methods 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 102000057297 Pepsin A Human genes 0.000 description 1
• 108090000284 Pepsin A Proteins 0.000 description 1
• 108010067902 Peptide Library Proteins 0.000 description 1
• 241000222393 Phanerochaete chrysosporium Species 0.000 description 1
• LTQCLFMNABRKSH-UHFFFAOYSA-N Phleomycin Natural products N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(O)C)NC(=O)C(C)C(O)C(C)NC(=O)C(C(OC1C(C(O)C(O)C(CO)O1)OC1C(C(OC(N)=O)C(O)C(CO)O1)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C LTQCLFMNABRKSH-UHFFFAOYSA-N 0.000 description 1
• 108010035235 Phleomycins Proteins 0.000 description 1
• 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
• 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
• 108010004729 Phycoerythrin Proteins 0.000 description 1
• 101100523938 Phytophthora infestans (strain T30-4) PexRD21 gene Proteins 0.000 description 1
• 241001281803 Plasmopara viticola Species 0.000 description 1
• 241000276498 Pollachius virens Species 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• RLNUPSVMIYRZSM-UHFFFAOYSA-N Pristinamycin Natural products CC1OC(=O)C(C=2C=CC=CC=2)NC(=O)C2CC(=O)CCN2C(=O)C(CC=2C=CC(=CC=2)N(C)C)CCN(C)C(=O)C2CCCN2C(=O)C(CC)NC(=O)C1NC(=O)C1=NC=CC=C1O RLNUPSVMIYRZSM-UHFFFAOYSA-N 0.000 description 1
• 108010079780 Pristinamycin Proteins 0.000 description 1
• 101710083689 Probable capsid protein Proteins 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 102000001253 Protein Kinase Human genes 0.000 description 1
• 102100039191 Protein MAL2 Human genes 0.000 description 1
• 108010026552 Proteome Proteins 0.000 description 1
• 241001123561 Puccinia coronata Species 0.000 description 1
• 241000221535 Pucciniales Species 0.000 description 1
• 229920001218 Pullulan Polymers 0.000 description 1
• 101150111199 RPC31 gene Proteins 0.000 description 1
• 101150026113 RVS161 gene Proteins 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 241000242743 Renilla reniformis Species 0.000 description 1
• 206010057190 Respiratory tract infections Diseases 0.000 description 1
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
• 101800000684 Ribonuclease H Proteins 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 101150054830 S100A6 gene Proteins 0.000 description 1
• 101100386089 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MET17 gene Proteins 0.000 description 1
• 101100478266 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SPT10 gene Proteins 0.000 description 1
• 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
• 241000235346 Schizosaccharomyces Species 0.000 description 1
• 241000221662 Sclerotinia Species 0.000 description 1
• 241000221696 Sclerotinia sclerotiorum Species 0.000 description 1
• 206010070834 Sensitisation Diseases 0.000 description 1
• 241000700584 Simplexvirus Species 0.000 description 1
• 108020004682 Single-Stranded DNA Proteins 0.000 description 1
• 244000061456 Solanum tuberosum Species 0.000 description 1
• 235000002595 Solanum tuberosum Nutrition 0.000 description 1
• 101710168938 Sphingosine-1-phosphate phosphatase 2 Proteins 0.000 description 1
• 241000222068 Sporobolomyces <Sporidiobolaceae> Species 0.000 description 1
• 101100309533 Stachybotrys chartarum (strain CBS 109288 / IBT 7711) SAT21 gene Proteins 0.000 description 1
• 108010090804 Streptavidin Proteins 0.000 description 1
• 108700005078 Synthetic Genes Proteins 0.000 description 1
• 108010017842 Telomerase Proteins 0.000 description 1
• 108020005038 Terminator Codon Proteins 0.000 description 1
• 241000248384 Tetrahymena thermophila Species 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 108090000190 Thrombin Proteins 0.000 description 1
• 102000006601 Thymidine Kinase Human genes 0.000 description 1
• 108020004440 Thymidine kinase Proteins 0.000 description 1
• 241000031845 Tilletia laevis Species 0.000 description 1
• 241000222355 Trametes versicolor Species 0.000 description 1
• 108700019146 Transgenes Proteins 0.000 description 1
• 241000499912 Trichoderma reesei Species 0.000 description 1
• 241000223230 Trichosporon Species 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 241001286670 Ulmus x hollandica Species 0.000 description 1
• 108091023045 Untranslated Region Proteins 0.000 description 1
• 206010046865 Vaccinia virus infection Diseases 0.000 description 1
• 241000317942 Venturia <ichneumonid wasp> Species 0.000 description 1
• 241001123669 Verticillium albo-atrum Species 0.000 description 1
• 241001123668 Verticillium dahliae Species 0.000 description 1
• 241000193620 Wickerhamia Species 0.000 description 1
• 241000235013 Yarrowia Species 0.000 description 1
• 241000235015 Yarrowia lipolytica Species 0.000 description 1
• 241000758405 Zoopagomycotina Species 0.000 description 1
• 241001360087 Zymoseptoria passerinii Species 0.000 description 1
• 241001360088 Zymoseptoria tritici Species 0.000 description 1
• 229940022698 acetylcholinesterase Drugs 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 229960000643 adenine Drugs 0.000 description 1
• 239000000556 agonist Substances 0.000 description 1
• 244000000022 airborne pathogen Species 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 210000001565 alc Anatomy 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 208000026935 allergic disease Diseases 0.000 description 1
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
• 230000037354 amino acid metabolism Effects 0.000 description 1
• 229940126575 aminoglycoside Drugs 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• 230000003172 anti-dna Effects 0.000 description 1
• 230000000340 anti-metabolite Effects 0.000 description 1
• 230000000259 anti-tumor effect Effects 0.000 description 1
• 230000000890 antigenic effect Effects 0.000 description 1
• 229940100197 antimetabolite Drugs 0.000 description 1
• 239000002256 antimetabolite Substances 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 239000002246 antineoplastic agent Substances 0.000 description 1
• 239000003816 antisense DNA Substances 0.000 description 1
• 239000000074 antisense oligonucleotide Substances 0.000 description 1
• 238000012230 antisense oligonucleotides Methods 0.000 description 1
• PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
• PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
• 108010005774 beta-Galactosidase Proteins 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 238000004166 bioassay Methods 0.000 description 1
• 238000010256 biochemical assay Methods 0.000 description 1
• 230000008238 biochemical pathway Effects 0.000 description 1
• 239000013060 biological fluid Substances 0.000 description 1
• 238000010170 biological method Methods 0.000 description 1
• 229920001222 biopolymer Polymers 0.000 description 1
• 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
• 229930189065 blasticidin Natural products 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 230000023852 carbohydrate metabolic process Effects 0.000 description 1
• 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 230000021523 carboxylation Effects 0.000 description 1
• 238000006473 carboxylation reaction Methods 0.000 description 1
• 230000021164 cell adhesion Effects 0.000 description 1
• 238000003352 cell adhesion assay Methods 0.000 description 1
• 230000006369 cell cycle progression Effects 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 230000004709 cell invasion Effects 0.000 description 1
• 230000004640 cellular pathway Effects 0.000 description 1
• 210000003850 cellular structure Anatomy 0.000 description 1
• 230000006364 cellular survival Effects 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
• 229960004475 chlortetracycline Drugs 0.000 description 1
• CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
• 235000019365 chlortetracycline Nutrition 0.000 description 1
• 238000011098 chromatofocusing Methods 0.000 description 1
• 238000011490 co-immunoprecipitation assay Methods 0.000 description 1
• 230000001332 colony forming effect Effects 0.000 description 1
• 229940000425 combination drug Drugs 0.000 description 1
• 238000003169 complementation method Methods 0.000 description 1
• 230000002508 compound effect Effects 0.000 description 1
• 238000013329 compounding Methods 0.000 description 1
• 238000000205 computational method Methods 0.000 description 1
• 238000004590 computer program Methods 0.000 description 1
• 238000012790 confirmation Methods 0.000 description 1
• 230000001268 conjugating effect Effects 0.000 description 1
• 239000013068 control sample Substances 0.000 description 1
• 239000005289 controlled pore glass Substances 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 238000012937 correction Methods 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 101150101363 cre-1 gene Proteins 0.000 description 1
• 230000002089 crippling effect Effects 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 239000003431 cross linking reagent Substances 0.000 description 1
• 229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 229940127089 cytotoxic agent Drugs 0.000 description 1
• 230000003013 cytotoxicity Effects 0.000 description 1
• 231100000135 cytotoxicity Toxicity 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 229960002398 demeclocycline Drugs 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 230000037304 dermatophytes Effects 0.000 description 1
• 230000001066 destructive effect Effects 0.000 description 1
• 230000034373 developmental growth involved in morphogenesis Effects 0.000 description 1
• 238000002405 diagnostic procedure Methods 0.000 description 1
• ANCLJVISBRWUTR-UHFFFAOYSA-N diaminophosphinic acid Chemical compound NP(N)(O)=O ANCLJVISBRWUTR-UHFFFAOYSA-N 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• RJBIAAZJODIFHR-UHFFFAOYSA-N dihydroxy-imino-sulfanyl-$l^{5}-phosphane Chemical compound NP(O)(O)=S RJBIAAZJODIFHR-UHFFFAOYSA-N 0.000 description 1
• 230000003292 diminished effect Effects 0.000 description 1
• NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
• 238000002224 dissection Methods 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• 101150076598 dnaB gene Proteins 0.000 description 1
• 229960003722 doxycycline Drugs 0.000 description 1
• 229940000406 drug candidate Drugs 0.000 description 1
• 238000007878 drug screening assay Methods 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 235000013399 edible fruits Nutrition 0.000 description 1
• 230000008030 elimination Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 238000010828 elution Methods 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 230000012202 endocytosis Effects 0.000 description 1
• 230000037149 energy metabolism Effects 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 230000009088 enzymatic function Effects 0.000 description 1
• 230000009483 enzymatic pathway Effects 0.000 description 1
• 238000001952 enzyme assay Methods 0.000 description 1
• 239000002532 enzyme inhibitor Substances 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 239000003925 fat Substances 0.000 description 1
• 235000019197 fats Nutrition 0.000 description 1
• 239000012467 final product Substances 0.000 description 1
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
• 108091006047 fluorescent proteins Proteins 0.000 description 1
• 102000034287 fluorescent proteins Human genes 0.000 description 1
• 229960002949 fluorouracil Drugs 0.000 description 1
• 230000005714 functional activity Effects 0.000 description 1
• 230000006650 fundamental cellular process Effects 0.000 description 1
• 230000008958 fungal pathogenicity Effects 0.000 description 1
• 239000000417 fungicide Substances 0.000 description 1
• 230000001408 fungistatic effect Effects 0.000 description 1
• 229930182830 galactose Natural products 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 238000002523 gelfiltration Methods 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 1
• 150000002402 hexoses Chemical class 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 1
• 229940097277 hygromycin b Drugs 0.000 description 1
• 230000009610 hypersensitivity Effects 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 208000026278 immune system disease Diseases 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 238000002649 immunization Methods 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 230000002163 immunogen Effects 0.000 description 1
• 229960003444 immunosuppressant agent Drugs 0.000 description 1
• 230000001861 immunosuppressant effect Effects 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 239000002596 immunotoxin Substances 0.000 description 1
• 238000007901 in situ hybridization Methods 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 229960003786 inosine Drugs 0.000 description 1
• 239000000138 intercalating agent Substances 0.000 description 1
• 230000009878 intermolecular interaction Effects 0.000 description 1
• 230000007154 intracellular accumulation Effects 0.000 description 1
• 230000009545 invasion Effects 0.000 description 1
• 238000011835 investigation Methods 0.000 description 1
• 238000004255 ion exchange chromatography Methods 0.000 description 1
• 238000001155 isoelectric focusing Methods 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• 238000005304 joining Methods 0.000 description 1
• 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
• 101150066555 lacZ gene Proteins 0.000 description 1
• 108020001756 ligand binding domains Proteins 0.000 description 1
• 230000037356 lipid metabolism Effects 0.000 description 1
• 230000029226 lipidation Effects 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 238000009630 liquid culture Methods 0.000 description 1
• 238000013332 literature search Methods 0.000 description 1
• 244000144972 livestock Species 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
• 108010059585 mRNA decapping enzymes Proteins 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 230000013011 mating Effects 0.000 description 1
• 229960000826 meclocycline Drugs 0.000 description 1
• 239000012533 medium component Substances 0.000 description 1
• 230000037353 metabolic pathway Effects 0.000 description 1
• 229910021645 metal ion Inorganic materials 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• IZAGSTRIDUNNOY-UHFFFAOYSA-N methyl 2-[(2,4-dioxo-1h-pyrimidin-5-yl)oxy]acetate Chemical compound COC(=O)COC1=CNC(=O)NC1=O IZAGSTRIDUNNOY-UHFFFAOYSA-N 0.000 description 1
• CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
• 229960000907 methylthioninium chloride Drugs 0.000 description 1
• HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 239000003094 microcapsule Substances 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 210000004688 microtubule Anatomy 0.000 description 1
• 230000008880 microtubule cytoskeleton organization Effects 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 229960002421 minocycline hydrochloride Drugs 0.000 description 1
• 238000001823 molecular biology technique Methods 0.000 description 1
• 238000009343 monoculture Methods 0.000 description 1
• 230000000877 morphologic effect Effects 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• 229960000951 mycophenolic acid Drugs 0.000 description 1
• HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
• ZTLGJPIZUOVDMT-UHFFFAOYSA-N n,n-dichlorotriazin-4-amine Chemical compound ClN(Cl)C1=CC=NN=N1 ZTLGJPIZUOVDMT-UHFFFAOYSA-N 0.000 description 1
• XJVXMWNLQRTRGH-UHFFFAOYSA-N n-(3-methylbut-3-enyl)-2-methylsulfanyl-7h-purin-6-amine Chemical compound CSC1=NC(NCCC(C)=C)=C2NC=NC2=N1 XJVXMWNLQRTRGH-UHFFFAOYSA-N 0.000 description 1
• 229950006780 n-acetylglucosamine Drugs 0.000 description 1
• 229930014626 natural product Natural products 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 229910052757 nitrogen Inorganic materials 0.000 description 1
• 108091027963 non-coding RNA Proteins 0.000 description 1
• 102000042567 non-coding RNA Human genes 0.000 description 1
• 238000003199 nucleic acid amplification method Methods 0.000 description 1
• 238000003499 nucleic acid array Methods 0.000 description 1
• 239000006916 nutrient agar Substances 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 235000014571 nuts Nutrition 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 235000019198 oils Nutrition 0.000 description 1
• 229940046166 oligodeoxynucleotide Drugs 0.000 description 1
• 238000006384 oligomerization reaction Methods 0.000 description 1
• 239000002751 oligonucleotide probe Substances 0.000 description 1
• 238000002515 oligonucleotide synthesis Methods 0.000 description 1
• 238000011275 oncology therapy Methods 0.000 description 1
• 244000039328 opportunistic pathogen Species 0.000 description 1
• 238000000424 optical density measurement Methods 0.000 description 1
• 238000005457 optimization Methods 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 229960000625 oxytetracycline Drugs 0.000 description 1
• IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
• 235000019366 oxytetracycline Nutrition 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 229940111202 pepsin Drugs 0.000 description 1
• 210000001322 periplasm Anatomy 0.000 description 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
• 239000003016 pheromone Substances 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
• 150000008300 phosphoramidites Chemical class 0.000 description 1
• 238000007747 plating Methods 0.000 description 1
• 101150005648 polB gene Proteins 0.000 description 1
• 229920001983 poloxamer Polymers 0.000 description 1
• 229920002401 polyacrylamide Polymers 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 229920000447 polyanionic polymer Polymers 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 229920005862 polyol Polymers 0.000 description 1
• 150000003077 polyols Chemical class 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 230000001323 posttranslational effect Effects 0.000 description 1
• 230000002028 premature Effects 0.000 description 1
• 230000037452 priming Effects 0.000 description 1
• 238000012913 prioritisation Methods 0.000 description 1
• 229960003961 pristinamycin Drugs 0.000 description 1
• DAIKHDNSXMZDCU-OUDXUNEISA-N pristinamycin-IIA Natural products CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c3coc(CC(=O)C[C@H](O)C=C(C)C=CCNC(=O)C=C[C@@H]1C)n3 DAIKHDNSXMZDCU-OUDXUNEISA-N 0.000 description 1
• JOOMGSFOCRDAHL-XKCHLWDXSA-N pristinamycin-IIB Natural products CC(C)[C@@H]1OC(=O)[C@H]2CCCN2C(=O)c3coc(CC(=O)C[C@@H](O)C=C(C)C=CCNC(=O)C=C[C@H]1C)n3 JOOMGSFOCRDAHL-XKCHLWDXSA-N 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 229940043274 prophylactic drug Drugs 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
• 230000001681 protective effect Effects 0.000 description 1
• 230000006916 protein interaction Effects 0.000 description 1
• 108060006633 protein kinase Proteins 0.000 description 1
• 230000009145 protein modification Effects 0.000 description 1
• 238000001742 protein purification Methods 0.000 description 1
• 238000001243 protein synthesis Methods 0.000 description 1
• 230000004850 protein–protein interaction Effects 0.000 description 1
• 230000002797 proteolythic effect Effects 0.000 description 1
• 235000019423 pullulan Nutrition 0.000 description 1
• ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
• 239000000985 reactive dye Substances 0.000 description 1
• 230000003716 rejuvenation Effects 0.000 description 1
• 238000009877 rendering Methods 0.000 description 1
• 230000008439 repair process Effects 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 108020004418 ribosomal RNA Proteins 0.000 description 1
• 210000003705 ribosome Anatomy 0.000 description 1
• 235000009566 rice Nutrition 0.000 description 1
• 238000013341 scale-up Methods 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 239000006152 selective media Substances 0.000 description 1
• 230000008313 sensitization Effects 0.000 description 1
• 230000001235 sensitizing effect Effects 0.000 description 1
• 238000013207 serial dilution Methods 0.000 description 1
• 239000013605 shuttle vector Substances 0.000 description 1
• 229960002930 sirolimus Drugs 0.000 description 1
• QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
• 229940048086 sodium pyrophosphate Drugs 0.000 description 1
• 230000037439 somatic mutation Effects 0.000 description 1
• 238000001179 sorption measurement Methods 0.000 description 1
• 238000001228 spectrum Methods 0.000 description 1
• 230000028070 sporulation Effects 0.000 description 1
• 230000010473 stable expression Effects 0.000 description 1
• 238000012289 standard assay Methods 0.000 description 1
• 238000005556 structure-activity relationship Methods 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 238000013268 sustained release Methods 0.000 description 1
• 239000012730 sustained-release form Substances 0.000 description 1
• 230000002195 synergetic effect Effects 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
• 238000012956 testing procedure Methods 0.000 description 1
• OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
• 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
• 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
• 229940126585 therapeutic drug Drugs 0.000 description 1
• ZEMGGZBWXRYJHK-UHFFFAOYSA-N thiouracil Chemical compound O=C1C=CNC(=S)N1 ZEMGGZBWXRYJHK-UHFFFAOYSA-N 0.000 description 1
• 229960004072 thrombin Drugs 0.000 description 1
• 230000000451 tissue damage Effects 0.000 description 1
• 231100000827 tissue damage Toxicity 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 230000005026 transcription initiation Effects 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 238000012085 transcriptional profiling Methods 0.000 description 1
• 238000005820 transferase reaction Methods 0.000 description 1
• 230000001131 transforming effect Effects 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 238000010798 ubiquitination Methods 0.000 description 1
• 230000034512 ubiquitination Effects 0.000 description 1
• ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
• HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
• 241000701447 unidentified baculovirus Species 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• 208000007089 vaccinia Diseases 0.000 description 1
• 239000004474 valine Substances 0.000 description 1
• 235000013311 vegetables Nutrition 0.000 description 1
• 230000009105 vegetative growth Effects 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
• WCNMEQDMUYVWMJ-JPZHCBQBSA-N wybutoxosine Chemical compound C1=NC=2C(=O)N3C(CC([C@H](NC(=O)OC)C(=O)OC)OO)=C(C)N=C3N(C)C=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O WCNMEQDMUYVWMJ-JPZHCBQBSA-N 0.000 description 1
• 229940075420 xanthine Drugs 0.000 description 1